Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Asset Writedowns and Impairment (2019 - 2025)

Evolus (EOLS) has disclosed Asset Writedowns and Impairment for 7 consecutive years, with $2.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Writedowns and Impairment rose 148.59% year-over-year to $2.2 million, compared with a TTM value of $4.8 million through Sep 2025, up 172.44%, and an annual FY2024 reading of $2.4 million, up 70.07% over the prior year.
  • Asset Writedowns and Impairment was $2.2 million for Q3 2025 at Evolus, up from $703000.0 in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $2.2 million in Q3 2025 and bottomed at -$297000.0 in Q2 2021.
  • Average Asset Writedowns and Impairment over 5 years is $528421.1, with a median of $582000.0 recorded in 2024.
  • The sharpest move saw Asset Writedowns and Impairment plummeted 89.04% in 2023, then skyrocketed 818.6% in 2024.
  • Year by year, Asset Writedowns and Impairment stood at $88000.0 in 2021, then surged by 792.05% to $785000.0 in 2022, then tumbled by 89.04% to $86000.0 in 2023, then surged by 818.6% to $790000.0 in 2024, then skyrocketed by 179.75% to $2.2 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for EOLS at $2.2 million in Q3 2025, $703000.0 in Q2 2025, and $1.1 million in Q1 2025.